Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$2.63
+5.20%
Ask drillr

Margins

Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
23.9%
Return on equity
14.9%
Return on assets
-107.7%
Return on invested capital
0.00x
Asset turnover
-$2.9M
Cash from operations
$0.12
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026